臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| Total items :0
	Visitors : 52611631 Online Users : 936 Project Commissioned by the Ministry of Education Project Executed by National Taiwan University Library

Scope

Adv. Search

Login

Administrator

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

About TAIR
	About TAIR

Browse By
	Institution
	Author
	Title
	Date
	Statistics Chart
	Institution Facts
	Trend

News
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

Copyright
	Publisher & Journal Policy
	TAIR Copyright Conference Minutes

Related Links
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"hsu c h"

Return to Browse by Author
Sorting by Title	Sort by Date

Showing items 491-500 of 1656 (166 Page(s) Totally)
<< < 45 46 47 48 49 50 51 52 53 54 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2021-03-15T07:44:47Z	Prognosis of patients with advanced hepatocellular carcinoma who failed first-line systemic therapy	Shao Y.-Y.; Wu C.-H.; LI-CHUN LU; Chan S.-Y.; Ma Y.-Y.; Yen F.-C.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2021-03-15T07:44:47Z	Clinical characteristics of advanced hepatocellular carcinoma patients with prolonged survival in the era of anti-angiogenic targeted-therapy	LI-CHUN LU; Shao Y.-Y.; Chan S.-Y.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2021-03-15T07:44:46Z	Tumor heterogeneity in hepatocellular carcinoma: Facing the challenges	LI-CHUN LU; Hsu C.-H.; Hsu C.; Cheng A.-L.
臺大學術典藏	2021-03-15T07:44:46Z	Tumor-associated neutrophils: An emerging player in the immune microenvironment of hepatocellular carcinoma	LI-CHUN LU; Hsu C.-H.
臺大學術典藏	2021-03-15T07:44:46Z	Treatment efficacy differences of sorafenib for advanced hepatocellular carcinoma: A meta-analysis of randomized clinical trials	Shao Y.-Y.; Shau W.-Y.; Chan S.-Y.; LI-CHUN LU; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2021-03-15T07:44:45Z	Prescription patterns of sorafenib and outcomes of patients with advanced hepatocellular carcinoma: A national population study	Li-Chun Lu;Chen P.-J.;Yeh Y.-C.;Hsu C.-H.;Chen H.-M.;Lai M.-S.;Shao Y.-Y.;Cheng A.-L.; LI-CHUN LU; Chen P.-J.; Yeh Y.-C.; Hsu C.-H.; Chen H.-M.; Lai M.-S.; Shao Y.-Y.; Cheng A.-L.
臺大學術典藏	2021-03-15T07:44:45Z	Inhibition of the Wnt/�]-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma	Lin H.-H.; Feng W.-C.; LI-CHUN LU; Shao Y.-Y.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2021-03-15T07:44:44Z	Targeting tumor-infiltrating Ly6G+ myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma	Chang C.-J.;Yang Y.-H.;Chiu C.-J.;Li-Chun Lu;Liao C.-C.;Liang C.-W.;Hsu C.-H.;Cheng A.-L.; Chang C.-J.; Yang Y.-H.; Chiu C.-J.; LI-CHUN LU; Liao C.-C.; Liang C.-W.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2021-03-15T07:44:44Z	Considerations of heterogeneity in clinical trials for hepatocellular carcinoma	Liu T.-H.;Shao Y.-Y.;Li-Chun Lu;Shen Y.-C.;Hsu C.;Lin Z.-Z.;Hsu C.-H.;Cheng A.-L.; Liu T.-H.; Shao Y.-Y.; LI-CHUN LU; Shen Y.-C.; Hsu C.; Lin Z.-Z.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2021-03-15T07:44:44Z	Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment	Li-Chun Lu;Lee Y.-H.;Chang C.-J.;Shun C.-T.;Fang C.-Y.;Shao Y.-Y.;Liu T.-H.;Cheng A.-L.;Hsu C.-H.; LI-CHUN LU; Lee Y.-H.; Chang C.-J.; Shun C.-T.; Fang C.-Y.; Shao Y.-Y.; Liu T.-H.; Cheng A.-L.; Hsu C.-H.

Showing items 491-500 of 1656 (166 Page(s) Totally)
<< < 45 46 47 48 49 50 51 52 53 54 > >>
View [10|25|50] records per page